MTOR and cervical carcinoma: One study documented that the expression of PI3k/Akt/mammalian target of rapamycin (mTOR) in cervical cancer tissues and in the exosomes derived from vaginal secretions was higher than that in the adjacent normal cervical tissues, but the expression levels did not significantly differ between cervical cancer tissues and the exosomes derived from vaginal secretions.129